Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

Wang Fangzheng; Jiang Chuner; Ye Zhimin; Sun Quanquan; Liu Tongxin; Xu Min; Wu Peng; Long Bin; Masoto Sakamoto; Wang Yuezhen; Yan Fengqin; Fu Zhenfu; Jiang Yangming

doi:10.18632/oncotarget.21587

journal article Oct 06, 2017

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

Wang Fangzheng Jiang Chuner Ye Zhimin Sun Quanquan Liu Tongxin Xu Min Wu Peng Long Bin Masoto Sakamoto Wang Yuezhen Yan Fengqin Fu Zhenfu Jiang Yangming

Oncotarget Vol. 8 No. 55 pp. 94117-94128 · Impact Journals, LLC

View at Publisher Save 10.18632/oncotarget.21587

Topics

No keywords indexed for this article. Browse by subject →

References

31

[1]

Jia "Global trends in incidence and mortality of nasopharyngeal carcinoma" Cancer Lett (2016) 10.1016/j.canlet.2016.01.040

[2]

Ma "The seventh edition of UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China" Radiother Oncol (2012) 10.1016/j.radonc.2011.10.009

[3]

Wee "Nasopharyngeal carcinoma: a promising future" Lancet Oncol (2012) 10.1016/s1470-2045(11)70321-7

[4]

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

Shu-Zhen Lai, Wen-Fei Li, Lei Chen et al.

International Journal of Radiation Oncology*Biolog... 2011 10.1016/j.ijrobp.2010.03.024

[5]

Reddy "Nasopharyngeal carcinoma" Curr Treat Options Oncol (2002) 10.1007/s11864-002-0038-8

[6]

Ensley "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099" J Clin Oncol (1998) 10.1200/jco.1998.16.4.1310

[7]

Yau "Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma" J Natl Cancer Inst (2010) 10.1093/jnci/djq258

[8]

Pignon "Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients" Int J Radiat Oncol Biol Phys (2006) 10.1016/j.ijrobp.2005.06.037

[9]

Xie "Significant efficacies of neoadjuvant chemotherapy and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, control trials" Ann Oncol (2013) 10.1093/annonc/mdt146

[10]

Ma "Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis of randomized controlled trials" J Cancer (2015) 10.7150/jca.11814

[11]

Han "Significant benefits of adding neoadjuvant chemotherapy before chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials" Oncotarget (2016) 10.18632/oncotarget.10237

[12]

Zee "Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma" J Clin Oncol (2009) 10.1200/jco.2008.18.1545

[13]

Athanassiou "Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patents with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation" Ann Oncol (2012) 10.1093/annonc/mdr116

[14]

Sun "A randomized trial of induction chemotherapy plus concurrent chemotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma" Oral Oncol (2012)

[15]

Chen "Induction chemotherapy plus concurrent chemotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomized controlled trial" Lancet Oncol (2016)

[16]

Lu "Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: final results of 2 parallel phase clinical trial" Cancer (2017) 10.1002/cncr.30566

[17]

Xu "The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemotherapy in nasopharyngeal carcinoma patients with N3 disease" Sci Rep (2017) 10.1038/s41598-017-03963-8

[18]

Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensitymatched analysis

Yu-Pei Chen, Yan-Ping Mao, Wen-Na Zhang et al.

Oncotarget 2016 10.18632/oncotarget.7789

[19]

Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area

Hu Liang, Yanyun Xiang, Xing Lv et al.

European Journal of Cancer 2017 10.1016/j.ejca.2016.12.009

[20]

Austin "The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies" Med Decis Making (2009) 10.1177/0272989x09341755

[21]

Zee "Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma" J Clin Oncol (2009) 10.1200/jco.2008.18.1545

[22]

Expanding global access to radiotherapy

Rifat Atun, David A Jaffray, Michael B Barton et al.

The Lancet Oncology 2015 10.1016/s1470-2045(15)00222-3

[23]

Ramirez "Influence of delay on survival in patients with breast cancer: a systematic review" Lancet (1999) 10.1016/s0140-6736(99)02142-x

[24]

The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery

Y.H. Yun, Y.A. Kim, Y.H. Min et al.

Annals of Oncology 2012 10.1093/annonc/mds101

[25]

Laupacis "Longer wait time increase overall mortality in patients with bladder cancer" J Urol (2009) 10.1016/j.juro.2009.06.041

[26]

Mackillop "The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature" Radiother Oncol (2008) 10.1016/j.radonc.2007.11.016

[27]

Ma "Optimized the cycle of neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a propensity score matching analysis" Oral Oncol (2016) 10.1016/j.oraloncology.2016.10.014

[28]

Fu "Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma" Oncotarget (2017) 10.18632/oncotarget.20017

[29]

Wang "Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma" Oncotarget (2017) 10.18632/oncotarget.18245

[30]

Fu "Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma" Oncotarget (2017) 10.18632/oncotarget.17357

[31]

Fu "Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma" Oncotarget (2017) 10.18632/oncotarget.14403

Metrics

10

Citations

31

References

Details

Published: Oct 06, 2017
Vol/Issue: 8(55)
Pages: 94117-94128

Authors

W

Wang Fangzheng

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China; Department of Radiology, Japanese Red Cross Fukui Hospital, Fukui 918-8501, Japan

J

Jiang Chuner

Department of Breast Tumor Surgery, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China

Y

Ye Zhimin

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

S

Sun Quanquan

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

L

Liu Tongxin

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

X

Xu Min

Department of Physics, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China

W

Wu Peng

Department of Pathology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China

L

Long Bin

Department of Nuclear Medicine, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China

M

Masoto Sakamoto

Department of Radiology, Japanese Red Cross Fukui Hospital, Fukui 918-8501, Japan

W

Wang Yuezhen

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

Y

Yan Fengqin

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

F

Fu Zhenfu

Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Hangzhou 310022, People’s Republic of China; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Hangzhou 310022, People’s Republic of China

J

Jiang Yangming

Department of Didital Earth, Institute of Remote Sensing and Didital Earth, CAS, Beijing 100101, People’s Republic of China

Cite This Article

Wang Fangzheng, Jiang Chuner, Ye Zhimin, et al. (2017). Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis. Oncotarget, 8(55), 94117-94128. https://doi.org/10.18632/oncotarget.21587

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

You May Also Like